Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4IBR9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 67 | 71 | PF00656 | 0.471 |
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.558 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.569 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.695 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.412 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.558 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.699 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.362 |
CLV_PCSK_PC1ET2_1 | 7 | 9 | PF00082 | 0.362 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.376 |
DOC_MAPK_gen_1 | 129 | 139 | PF00069 | 0.376 |
DOC_MAPK_gen_1 | 47 | 57 | PF00069 | 0.475 |
DOC_MAPK_MEF2A_6 | 50 | 59 | PF00069 | 0.291 |
DOC_PP1_RVXF_1 | 105 | 112 | PF00149 | 0.356 |
DOC_PP4_FxxP_1 | 27 | 30 | PF00568 | 0.585 |
LIG_14-3-3_CanoR_1 | 37 | 46 | PF00244 | 0.673 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.581 |
LIG_deltaCOP1_diTrp_1 | 110 | 118 | PF00928 | 0.363 |
LIG_eIF4E_1 | 51 | 57 | PF01652 | 0.310 |
LIG_FHA_2 | 119 | 125 | PF00498 | 0.391 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.420 |
LIG_HP1_1 | 58 | 62 | PF01393 | 0.304 |
LIG_LIR_Gen_1 | 133 | 139 | PF02991 | 0.370 |
LIG_LIR_Gen_1 | 74 | 85 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 133 | 137 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 41 | 46 | PF02991 | 0.554 |
LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.366 |
LIG_OCRL_FandH_1 | 76 | 88 | PF00620 | 0.349 |
LIG_Pex14_1 | 48 | 52 | PF04695 | 0.310 |
LIG_Pex14_2 | 27 | 31 | PF04695 | 0.590 |
LIG_PTB_Apo_2 | 96 | 103 | PF02174 | 0.384 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.316 |
LIG_TRAF2_1 | 30 | 33 | PF00917 | 0.599 |
LIG_TYR_ITIM | 49 | 54 | PF00017 | 0.388 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.584 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.368 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.420 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.643 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.428 |
MOD_PKA_2 | 105 | 111 | PF00069 | 0.383 |
MOD_PKA_2 | 118 | 124 | PF00069 | 0.354 |
MOD_PKA_2 | 14 | 20 | PF00069 | 0.574 |
MOD_PKA_2 | 140 | 146 | PF00069 | 0.429 |
MOD_PKA_2 | 33 | 39 | PF00069 | 0.625 |
MOD_Plk_2-3 | 105 | 111 | PF00069 | 0.407 |
MOD_Plk_2-3 | 124 | 130 | PF00069 | 0.277 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.417 |
MOD_SUMO_for_1 | 9 | 12 | PF00179 | 0.578 |
MOD_SUMO_rev_2 | 104 | 113 | PF00179 | 0.393 |
TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.544 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.313 |
TRG_ER_diArg_1 | 34 | 37 | PF00400 | 0.612 |
TRG_NLS_MonoExtC_3 | 6 | 12 | PF00514 | 0.578 |
TRG_Pf-PMV_PEXEL_1 | 129 | 133 | PF00026 | 0.580 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3X2 | Leptomonas seymouri | 89% | 100% |
A0A0S4J4A6 | Bodo saltans | 77% | 96% |
A0A1X0P575 | Trypanosomatidae | 84% | 99% |
A0A3Q8IMS0 | Leishmania donovani | 99% | 100% |
A0A3R7M4Q6 | Trypanosoma rangeli | 77% | 99% |
A4HN52 | Leishmania braziliensis | 98% | 100% |
C9ZYV3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 83% | 75% |
E9AFK5 | Leishmania major | 98% | 100% |
E9B6Q9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |